Abstract: 2 experiments indicate that CS-US contingency is an important determinant of fear conditioning and that presentation of US in the absence of CS interferes with fear conditioning. In Experiment 1, equal probability of a shock US in the presence and absence of a tone CS produced no CER suppression to CS; the same probability of US given only during CS produced substantial conditioning. In Experiment 2, which explored 4 different probabilities of US in the presence and absence of CS, amount of conditioning was higher the greater the probability of US during CS and was lower the greater the probability of US in the absence of CS; when the 2 probabilities were equal, no conditioning resulted. Two conceptions of Pavlovian conditioning have been distinguished by Rescorla (1967). The first, and more traditional, notion emphasizes the role of the number of pairings of CS and US in the formation of a CR. The second notion suggests that it is the contingency between CS and US which is important. The notion of contingency differs from that of pairing in that it includes not only what events are paired but also what events are not paired. As used here, contingency refers to the relative probability of occurrence of US in the presence of CS as contrasted with its probability in the absence of CS. The contingency notion suggests that, in fact, conditioning only occurs when these probabilities differ; when the probability of US is higher during CS than at other times, excitatory conditioning occurs; when the probability is lower, inhibitory conditioning results. Notice that the probability of a US can be the same in the absence and presence of CS and yet there can be a fair number of CS-US pairings. It is this that makes it possible to assess the relative importance of pairing and contingency in the development of a CR. Several experiments have pointed to the usefulness of the contingency notion. Rescorla (1966) reported a Pavlovian 1This research was supported by Grants MH13415-01 from the National Institute of Mental Health and GB-6493 from the National Science Foundation, as well as by funds from Yale University.